Related Experiment Video

Updated: Aug 18, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

The interaction of coronary tone and cardiac fibrosis

Matthew T Wheeler1, Elizabeth M McNally

  • 1Section of Cardiology, Department of Medicine, The University of Chicago, 5841 South Maryland Avenue, MC 6088, Chicago, IL 60637, USA.

Current Atherosclerosis Reports
|April 7, 2005
PubMed

Insights

Coronary vascular dysfunction impairs heart blood flow and can lead to myocardial fibrosis. This review examines how cardiovascular agents affect fibrosis and myofibroblast activity in the heart.

Area of Science:

  • Cardiovascular Science
  • Cardiac Pathophysiology
  • Myocardial Remodeling

Background:

  • Regulation of coronary vascular tone is vital for heart perfusion and function.
  • Coronary vascular dysfunction, from atherosclerosis to metabolic issues, impairs this regulation.
  • This dysfunction often leads to myocardial fibrosis and altered heart structure.

Purpose of the Study:

  • To review current literature on myocardial fibrosis and myofibroblast activity.
  • To explore the mechanisms linking coronary vascular dysregulation to fibrosis.
  • To highlight the impact of cardiovascular agents on cardiac remodeling.

Main Methods:

  • Literature review of recent studies on myocardial fibrosis.
  • Analysis of the role of fibroblasts and myofibroblasts in cardiac disease.
  • Examination of cardiovascular agents' effects on the remodeling process.

Main Results:

  • Coronary vascular dysregulation contributes significantly to myocardial fibrosis.
  • Fibroblasts and myofibroblasts play a key role in cardiac remodeling.
  • Cardiovascular agents show potential in modulating these fibrotic processes.

Conclusions:

  • Understanding coronary vascular tone regulation is crucial for preventing myocardial fibrosis.
  • Targeting fibroblasts and myofibroblasts offers therapeutic potential for heart disease.
  • Further research into cardiovascular agents is needed to combat cardiac remodeling.

More Related Videos

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...